Lyrica Generics Likely Delayed By A Pfizer Labeling Supplement

stopping the Dominio effect
A labeling update approved just before patent expiry may have caused Lyrica generics to be cleared later than expected in the US . • Source: Shutterstock

More from Generics

More from Biosimilars & Generics